Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 5, 2013, Pages

  Goldenberg, Joshua Z ^a   Ma, Stephanie S Y ^b   Saxton, Jane D ^a   Martzen, Mark R ^a   Vandvik, Per O ^c   Thorlund, Kristian ^b   Guyatt, Gordon H ^b   Johnston, Bradley C ^d,e  

^a BASTYR UNIVERSITY   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG EFFICACY; FEVER; FLATULENCE; HUMAN; LENGTH OF STAY; META ANALYSIS; NAUSEA; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TASTE DISORDER; ADULT; CHILD; COMPLICATION; MICROBIOLOGY; PSEUDOMEMBRANOUS COLITIS; CLOSTRIDIUM DIFFICILE;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891816574     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006095.pub3     Document Type: Review

References (152)

1. Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula L, et al.Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104(5):e64.
2. Beausoleil M, Fortier N, Guenette S, L'Ecuyer A, Savoie M, Franco M, et al.Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Canadian Journal of Gastroenterology 2007;21(11):732-6.
3. Bravo MV, Bunout D, Leiva L, de la Maza MP, Barrera G, de la Maza J, et al.Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment [Efecto del probiótico Saccharomycesboulardii en la prevención de ladiarrea asociada con antibióticos enadultos ambulatorios en tratamientocon amoxicilina]. Revista Médica de Chile 2008;136(8):981-8.
4. Can M, Beşirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Medical Science Monitor 2006;12(4):Pi19-22.
5. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 2007;12(4):309-16.
6. Duman DG, Bor S, Ozütemiz O, Sahin T, Oğuz D, Iştan F, et al.Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. European Journal of Gastroenterology and Hepatology 2005;17(12):1357-61.
7. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology 2010;105(7):1636-41.
8. Hickson, M, D'Souza, AL, Muthu, N, Rogers, TR, Want, S, Rajkumar, C, & Bulpitt, CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007;335(7610):80.
9. Imase K, Takahashi M, Tanaka A, Tokunaga K, Sugano H, Tanaka M, et al.Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota. Microbiology and Immunology 2008;52(3):156-61.
10. Klarin B, Wullt M, Palmquist I, Molin G, Larsson A, Jeppsson B. Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiologica Scandinavica 2008;52(8):1096-102.
11. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrugger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. American Journal of Gastroenterology 2008;103(1):178-89.
12. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology and Therapeutics 2005;21(5):583-90.
13. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. Journal of Infection 1998;36(2):171-4.
14. Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. Journal of Clinical Gastroenterology 2010;44(2):106-12.
15. McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, et al.Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. American Journal of Gastroenterology 1995;90(3):439-48.
16. Nord CE, Lidbeck A, Orrhage K, Sjostedt S. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin. Clinical Microbiology and Infection 1997;3(1):124-32.
17. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. International Microbiology 2004;7(1):59-62.
18. Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, et al.Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. American Journal of Gastroenterology 2012;107(6):922-31.
19. Psaradellis E, Sampalis J, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study. Archives of Medical Science 2010;6(1):56-64.
20. Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Alimentary Pharmacology and Therapeutics 2008;28(1):154-61.
21. Safdar N, Barigala R, Said A, McKinley L. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. Journal of Clinical Pharmacy and Therapeutics 2008;33(6):663-8.
22. Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, et al.Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World Journal of Gastroenterology 2005;11(47):7520-4.
23. Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, et al.Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Annals of Medicine 1990;22(1):57-9.
24. Sullivan A, Johansson A, Svenungsson B, Nord CE. Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora. Journal of Antimicrobial Chemotherapy 2004;54(4):791-7.
25. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;96(4):981-8.
26. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clinic Proceedings 2001;76(9):883-9.
27. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. European Journal of Clinical Nutrition 2008;62(2):299-301.
28. Agarwal R, Sharma N, Chaudhry R, Deorari A, Paul VK, Gewolb IH, et al.Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. Journal of Pediatric Gastroenterology and Nutrition 2003;36(3):397-402.
29. Allen SJ, Wareham K, Bradley C, Harris W, Dhar A, Brown H, et al.A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol. BMC Infectious Diseases 2012;12:108.
30. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, et al.Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infection 2006;8(6):1450-4.
31. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, et al.The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics 2001;15(2):163-9.
32. Avadhani A, Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis. Journal of the American Academy of Nurse Practitioners 2011;23(6):269-74.
33. Basu S, Chatterjee M, Ganguly S, Chandra PK. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial. Journal of Paediatrics and Child Health 2007;43(12):837-42.
34. Bekar O, Yilmaz Y, Gulten M. Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. Journal of Medicinal Food 2011;14(4):344-7.
35. Bellomo G, Mangiagle A, Nicastro L, Frigerio G. A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhoea in pediatrics. Current Therapeutic Research, Clinical and Experimental 1980;28(6i):927-36.
36. Benhamou PH, Berlier P, Danjou G, Plique O, Jessueld D, Dupont C. Antibiotic-associated diarrhoea in children: A computer monitored double-blind outpatients trial comparing a protective and a probiotic agent. Medecine et Chirurgie Digestives 1999;28(4):163-8.
37. Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, et al.A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Digestive Diseases and Sciences 2003;48(10):2077-82.
38. Berni Canani R, Cucchiara S, Cuomo R, Pace F, Papale F. Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children. European Review for Medical and Pharmacological Sciences 2011;15(7):809-22.
39. Black F, Einarsson K, Lidbeck A, Orrhage K, Nord CE. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scandinavian Journal of Infectious Diseases 1991;23(2):247-54.
40. Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Medicine 1997;23(5):517-23.
41. Brunser O, Gotteland M, Cruchet S, Figueroa G, Garrido D, Steenhout P. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatric Research 2006;59(3):451-6.
42. Butler CC, Duncan D, Hood K. Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea?. BMJ (Clinical Research Ed.) 2012;344:e682.
43. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains?. European Journal of Nutrition 2011;50(1):1-17.
44. Chen CC, Walker WA. Clinical applications of probiotics in gastrointestinal disorders in children. National Medical Journal of India 2011;24(3):153-60.
45. Cimperman L, Bayless G, Best K, Diligente A, Mordarski B, Oster M, et al.A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. Journal of Clinical Gastroenterology 2011;45(9):785-9.
46. Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, et al.Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy 1981;20(1):104-8.
47. Contardi I. Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood [Batterioterapia orale quale prevenzione della diarrea da antibiotici in eta pediatrica]. La Clinica Terapeutica 1991;136(6):409-13.
48. Conway S, Hart A, Clark A, Harvey I. Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. British Journal of General Practice 2007;57(545):953-9.
49. Correa NB, Peret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. Journal of Clinical Gastroenterology 2005;39(5):385-9.
50. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, et al.Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. American Journal of Gastroenterology 2002;97(11):2744-9.
51. de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, et al.Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. American Journal of Gastroenterology 2007;102(5):951-6.
52. de Vrese M, Kristen H, Rautenberg P, Laue C, Schrezenmeir J. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. Journal of Dairy Research 2011;78(4):396-403.
53. Elmer GW, McFarland LV, Surawicz CM, Danko L, Greenberg RN. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Alimentary Pharmacology and Therapeutics 1999;13(12):1663-8.
54. Erdeve O, Tiras U, Dallar Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. Journal of Tropical Pediatrics 2004;50(4):234-6.
55. Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, et al.Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European Journal of Gastroenterology and Hepatology 2001;13(1):25-9.
56. Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Critical Care 2008;12(3):R69.
57. Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Maurogiovanni G, Bucci N, et al.Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 2008;13(2):127-34.
58. Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, et al.Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006;22(10):984-8.
59. Gotteland M, Poliak L, Cruchet S, Brunser O. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatrica 2005;94(12):1747-51.
60. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. American Journal of Hospital Pharmacy 1979;36(6):754-7.
61. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al.Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition 2000;30(1):54-60.
62. Hafeez A, Tariq P, Ali S, Kundi ZU, Khan A, Hassan M. The efficacy of Saccharomyces boulardii in the treatment of acute watery diarrhea in children: A multicentre randomized controlled trial. Journal of the College of Physicians and Surgeons Pakistan 2002;12(7):432-4.
63. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al.Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001;322(7298):1327.
64. Heimburger DC, Sockwell DG, Geels WJ. Diarrhea with enteral feeding: prospective reappraisal of putative causes. Nutrition 1994;10(5):392-6.
65. Hotz J. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study [Verhutung der antibiotika-assoziierten Diarrhoe durch Saccharomyces boulardii: Eine prospektive Studie]. Zeitschrift fur Gastroenterologie 1990;28(5):259-60.
66. Hurduc V, Plesca D, Dragomir D, Sajin M, Vandenplas Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatrica 2009;98(1):127-31.
67. Jacobi CA, Malfertheiner P. Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Digestive Diseases 2011;29(6):600-7.
68. Jirapinyo P, Densupsoontorn N, Thamonsiri N, Wongarn R. Prevention of antibiotic-associated diarrhea in infants by probiotics. Journal of the Medical Association of Thailand 2002;85 Suppl 2:S739-42.
69. Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, et al.Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Alimentary Pharmacology and Therapeutics 2004;20(10):1133-41.
70. Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study [Prophylaxe der Reisediarrhoe mit Saccharomyces boulardii. Ergebnisse einer plazebokontrollierten Doppelblindstudie]. Fortschritte der Medizin 1993;111(9):152-6.
71. Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. International Journal of Colorectal Disease 2012;27(4):467-74.
72. La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, Ini G, et al.Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study [Prevenzione della diarrea associata ad antibiotici con Lactobacillus sporogenes e frutto-oligosaccaridi. Studio pediatrico multicentrico in doppio cieco vs placebo]. Minerva pediatrica 2003;55(5):447-52.
73. Lawrence SJ, Korzenik JR, Mundy LM. Probiotics for recurrent Clostridium difficile disease. Journal of Medical Microbiology 2005; Vol. 54, issue Pt 9:905-6.
74. Lei V, Friis H, Michaelsen KF. Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: an intervention study in Northern Ghana. International Journal of Food Microbiology 2006;110(3):246-53.
75. Lionetti E, Miniello VL, Castellaneta SP, Magista AM, de Canio A, Maurogiovanni G, et al.Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Alimentary Pharmacology and Therapeutics 2006;24(10):1461-8.
76. Madden JA, Plummer SF, Tang J, Garaiova I, Plummer NT, Herbison M, et al.Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. International Immunopharmacology 2005;5(6):1091-7.
77. Madeo M, Whitlock M, Martin CR. A randomized controlled trial comparing Lactobacillus combined with Bifidobacterium bifidum against fructo-oligosaccharides in reducing the incidence of antibiotic-associated diarrhoea: a preliminary investigation. Clinical Effectiveness in Nursing 1999;3(2):83-7.
78. Marcone V, Calzolari E, Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiologica 2008;31(3):429-33.
79. Marshall JC. Daily use of a Lactobacilli probiotic prevented antibiotic-associated diarrhea in hospitalized patients. ACP Journal Club 2008;149(1):10.
80. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, et al.Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Canadian Journal of Microbiology 2009;55(2):133-8.
81. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al.A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271(24):1913-8.
82. Merenstein DJ, Foster J, D'Amico F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Archives of Pediatrics and Adolescent Medicine 2009;163(8):750-4.
83. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010;98(2):156-63.
84. Mohan R, Koebnick C, Schildt J, Mueller M, Radke M, Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatric Research 2008;64(4):418-22.
85. Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, et al.Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Alimentary Pharmacology and Therapeutics 2005;21(10):1263-72.
86. Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. International Journal of Antimicrobial Agents 2007;29(1):66-72.
87. Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, et al.Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Alimentary Pharmacology and Therapeutics 2004;20(10):1181-8.
88. Oleinichenko EV, Mitrokhin SD, Nonikov VE, Minaev VI. Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy [Effektivnost' atsipola v profilaktike disbakterioza kishechnika pri antibakterial'noi terapii]. Antibiotiki i Khimioterapiia 1999;44(1):23-5.
89. Ozdil K, Calhan T, Sahin A, Senates E, Kahraman R, Yuzbasioglu B, et al.Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication. Hepato-Gastroenterology 2011;58(109):1148-52.
90. Park SK, Park DI, Choi JS, Kang MS, Park JH, Kim HJ, et al.The effect of probiotics on Helicobacter pylori eradication. Hepato-Gastroenterology 2007;54(79):2032-6.
91. Pereg D, Kimhi O, Tirosh A, Orr N, Kayouf R, Lishner M. The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. American Journal of Infection Control 2005;33(2):122-5.
92. Pirotta M, Gunn J, Chondros P, Grover S, Hurley S, Garland S. The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]. BMC Family Practice 2004;5:5.
93. Plewinska EM, Planeta-Malecka I, Bak-Romaniszyn L, Czkwianlanc E, Malecka-Panas E. Probiotics in the treatment of Helicobacter pylori infection in children. Gastroenterologia Polska 2006;13(4):315-9.
94. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. American Journal of Gastroenterology 2000;95(1 Suppl):S11-3.
95. Potts L, Lewis SJ, Barry R. Randomised double blind placebo controlled study of the ability of saccharomyces boulardii to prevent antibiotic related diarrhoea. Gut 1996;38 Suppl 1:A61.
96. Pushkarev AM. Efficacy of probiotic bactisporin in therapy of intrahospital urinary infection. Urologiia 2005, (4):48-53.
97. Ranasinghe JGS, Gamlath GRRDK, Samitha S, Abeygunawardena AS. Prophylactic use of yoghurt reduces antibiotic induced diarrhoea in children. Sri Lanka Journal of Child Health 2007;36(2):53-6.
98. Rayes N, Hansen S, Seehofer D, Muller AR, Serke S, Bengmark S, et al.Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002;18(7-8):609-15.
99. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al.Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002;74(1):123-7.
100. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, Neuhaus P. Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial [Einfluss von Probiotika und Ballaststoffen auf die Inzidenz bakterieller Infektionen nach viszeralchirurgischen Eingriffen - Ergebnisse einer prospektiven Studie]. Zeitschrift fur Gastroenterologie 2002;40(10):869-76.
101. Reddy BS, Macfie J, Gatt M, Larsen CN, Jensen SS, Leser TD. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. British Journal of Surgery 2007;94(5):546-54.
102. Robertson J. Lactobacillus GG reduced diarrhoea incidence in antibiotic treated children. Evidence-Based Nursing 2000;3(3):76.
103. Sahagún-Flores JE, López-Peña LS, de la Cruz-Ramírez Jaimes J, García-Bravo MS, Peregrina-Gómez R, de Alba-García JE. Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone. Cirugia y Cirujanos 2007;75(5):333-6.
104. Schrezenmeir J, McCue M, Llamas C, Lam W, Lamsbach M, Comer GM. Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. American Journal of Clinical Nutrition 2002;75(2):400S.
105. Schrezenmeir J, Heller K, McCue M, Llamas C, Lam W, Burow H, et al.Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. Clinical Pediatrics 2004;43(3):239-49.
106. Sepp E, Stsepetova J, Smidt I, Ratsep M, Koljalg S, Loivukene K, et al.Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe 2011;17(6):407-9.
107. Souza DN, Jorge MT. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial. Revista da Sociedade Brasileira de Medicina Tropical 2012;45(1):112-6.
108. Stein GY, Nanim R, Karniel E, Moskowitz I, Zeidman A. Probiotics as prophylactic agents against antibiotic-associated diarrhea in hospitalized patients. Harefuah 2007;146(7):520-2, 575.
109. Stockenhuber A, Kamhuber C, Leeb G, Adelmann K, Prager E, Mach K, et al.Preventing antibiotic associated diarrhoea using a probiotic Lactobacillus Casei preparation. United European Gastroenterology Week. 2008.
110. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990;24(4):382-4.
111. Tursi A, Brandimarte G, Giorgetti GM, Modeo ME. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Medical Science Monitor 2004;10(12):CR662-6.
112. Vandenplas Y, De Hert SG. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children. Alimentary Pharmacology and Therapeutics 2011;34(8):862-7.
113. Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. Annals of Pharmacotherapy 2011;45(7-8):960-6.
114. Witsell DL, Garrett CG, Yarbrough WG, Dorrestein SP, Drake AF, Weissler MC. Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial. Journal of Otolaryngology 1995;24(4):230-3.
115. Woo K. A probiotic drink prevented diarrhoea and Clostridium difficile-associated diarrhoea in older patients taking antibiotics. Evidence-Based Nursing 2008;11(2):57.
116. Wullt M, Johansson Hagslatt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea. Digestive Diseases and Sciences 2007;52(9):2082-6.
117. Yoon H, Kim N, Kim JY, Park SY, Park JH, Jung HC, et al.Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2011;26(1):44-8.
118. Yost RL, Gotz VP. Effect of a lactobacillus preparation on the absorption of oral ampicillin. Antimicrobial Agents and Chemotherapy 1985;28(6):727-9.
119. Ziemniak W. Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. Journal of Physiology and Pharmacology 2006;57 Suppl 3:123-41.
120. Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, et al.Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ 2012;344:e2809.
121. Akl EA, Johnston BC, Neumann I, Alonso-Coello P, Cook DJ, Guyatt GH. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One 2013;8(2):e57132.
122. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. Journal of the National Cancer Institute 1989;81(2):107-15.
123. Berrington A. Impact of mandatory Clostridium difficile surveillance on diagnostic services. Journal of Hospital Infection 2004;58(3):241-2.
124. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhoea: meta-analysis. BMJ 2002;324(7350):1361-7.
125. Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. Canadian Medical Association Journal 2005;173(2):167-70.
126. Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Evaluation of five probiotics products for label claims by DNA extraction and polymerase chain reaction analysis. Digestive Diseases and Sciences 2005;50(6):1113-7.
127. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
128. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. Journal of Hospital Infection 2010;74(4):309-18.
129. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
130. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443-57.
131. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al.Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307(18):1959-69.
132. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
133. Higgins JPT, Green (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org, 2011.
134. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. Canadian Medical Association Journal 2006;175(4):377-83.
135. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD004827.pub3].
136. Johnston BC, Ma SSY, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al.Probiotics for the prevention of Clostridium difficile-associated diarrhea: systematic review and meta-analysis. Annals of Internal Medicine 2012;157(12):878-88.
137. Langan D, Higgins JP, Gregory W, Sutton AJ. Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. Journal of Clinical Epidemiology 2012;65(5):511-9.
138. Lumley T. rmeta: Meta-Analysis. R package version 2.16, 2009.
139. McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology 2010;16(18):2202-22.
140. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2010.
141. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
142. Schwarzer G. meta: Meta-Analysis with R. R package version 1.6-0, 2010.
143. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000;53(11):1119-29.
144. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al.Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
145. Sullivan A, Nord C. Probiotics in human infections. Journal of Antimicrobial Chemotherapy 2002;50(5):625-7.
146. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117.
147. Thompson, S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309(6965):1351-1355.
148. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted?. Statistics in Medicine 2002;21(11):1559-73.
149. Viechtbauer W. Conducting meta-analysis in R with the metafor package. Journal of Statistical Software 2010;36(3):1-48.
150. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. American Journal of Clinical Nutrition 2010;91(3):687-703.
151. Williamson PR, Gamble C. Identification and impact of outcome selection bias in meta-analysis. Statistics in Medicine 2005;24(10):1547-61.
152. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601-5.